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Introduction 
 Intimate partner violence (IPV) affects millions of men and women annually in the 
United States1, 2, and represents a significant source of morbidity and mortality3-5. There 
are slight variations between definitions of IPV in the literature, though the definition 
provided by the Centers for Disease Control and Prevention (CDC) is often cited and 
includes a variety of types of behavior that qualify as intimate partner violence. The 
definition of IPV as provided by the CDC is as follows: “Intimate partner violence 
includes physical violence, sexual violence, stalking and psychological aggression 
(including coercive tactics) by a current or former intimate partner (i.e., spouse, 
boyfriend/girlfriend, dating partner, or ongoing sexual partner”)2. Physicians are in an 
ideal position to identify IPV, as they regularly care for patients who are victims of 
trauma and often engage in sensitive conversations with their patients regarding their 
social situations. Research which has examined physician attitudes demonstrates that 
physicians frequently believe that they have a role to play in screening for IPV in their 
patients and conducting brief assessments and referral to IPV services, though many 
barriers exist which prevent them from adequately addressing this problem. To date, 
there has not been a study of US primary care physicians’ attitudes and beliefs towards 
discovering, evaluating, and managing IPV in their patients. This study serves to 
examine physicians’ perceived roles in and barriers to managing IPV in the primary care 
setting.  
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Background 
Intimate partner violence has long been acknowledged as a medical and public 
health problem with documented serious implications for the health of victims and 
families1, 6-7. It is estimated that 1.5 million women in the United States experience 
physical and/or sexual violence by an intimate partner each year1, 4, 8-10, which is an 
estimate derived from the 1995-96 National Violence Against Women (NVAW) survey45. 
However, more recent data from the National Intimate Partner and Sexual Violence 
Survey (NISVS) indicate that nearly 10 million women and men per year are victims of 
physical violence by a current or former intimate partner2. Lifetime rates of IPV against 
women are between 25-31%1, and one in 11 women in the US (8.8%) have been raped 
over their lifetimes by a current or former intimate partner2. Physical violence occurs in 
up to 6 million intimate partner relationships per year11, and IPV is almost always a 
feature of active, past, or thwarted sexual relationships12. Despite the fact that women 
are nearly universally at greater risk of physical and sexual violence from current or 
former intimate partners than from other sources13, women are more often afraid of 
violence from strangers14. In studies of female homicide victims, anywhere from 30-60% 
of women who are murdered are killed by current or former intimate partners1, 8, 15-16, 
and in many of these situations the woman was physically abused prior to her death16. 
For young African-American women (ages 15-34 years), murder by an intimate partner 
is the leading cause of death in the US8. IPV is estimated to cause nearly 2 million 
injuries and 1300 deaths annually17.  
Just as the definition of IPV is broad and includes different types of behavior, the 
consequences of experiencing IPV are varied for victims. Victims of IPV are at greater 
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risk for a number of physical health ailments including gastrointestinal disorders and 
gynecological conditions, mental health ailments including depression and suicidal 
ideation, and increased substance use1, 3-5, 16, 18. Increased rates of gynecological 
conditions represent the most readily identified distinction in health status between 
abused and non-abused women, with sexually transmitted infections, vaginal bleeding, 
chronic pelvic pain, and urinary tract infections occurring much more frequently in 
abused women15. Women who experience IPV are at greater risk for depression and 
post-traumatic stress disorder (PTSD) than women who have histories of childhood 
sexual abuse15. Victims of IPV incur 2-2.5 times the health care costs of non-victims1. It 
is estimated that the annual economic impact of IPV is $4.1 billion in direct medical 
costs with an additional $1.8 billion in related costs17.  
Data show that women are disproportionately represented as victims of IPV with 
men as perpetrators11, though approximately 800,000 men annually and 14% of men 
over their lifetimes experience IPV2, 8. Both males and females are vulnerable to 
different types of IPV, though females are at greater risk for physical assault and sexual 
coercion19, 20, with males reporting higher rates of psychological abuse alone20. 
Psychological abuse may account for nearly half of IPV among women and 78% of IPV 
among men, with 14% of women and 18% of men having experienced psychological 
abuse alone over their lifetimes20. Additionally, female victims of IPV report that they are 
fearful of their partners at much higher rates than male victims (28.8% of female vs. 
5.2% of male victims), and are over three times more likely to be injured by an intimate 
partner19. Furthermore, women are at much greater risk for experiencing lethal abuse by 
men than men are by women21. 
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While IPV has known adverse effects for victims themselves, there are often 
other parties which may be negatively impacted by IPV. Children have often been 
treated as tangential to violence between intimate partners21, but children of abused 
women are often aware of ongoing abuse more than their parents acknowledge16. 
Children exposed to abuse of their mothers demonstrate higher levels of anxiety, 
aggressive behaviors, social withdrawal, hyperactivity, physical symptoms (including 
bed wetting and disturbed sleep), and suicidal ideation16. Children raised in the 
presence of IPV may experience disorganized attachment to their mothers, and may 
actually carry out their own physical aggression towards their mothers21. The presence 
of IPV also increases the risk of direct physical and sexual abuse of children, with 45-
70% overlap demonstrated between domestic violence and physical child abuse21. IPV 
also contributes to low infant birthweights in abused pregnant women15, 16, with IPV 
occurring in anywhere from 3-13% of pregnancies worldwide15. 
Despite that IPV is highly prevalent across a diverse population, certain individual 
characteristics are associated with additional risk for experiencing IPV22. Increased 
education and socioeconomic status are associated with decreased prevalence of IPV 
in women when compared to women with lower socioeconomic status15. Poverty is 
thought to contribute to IPV in a number of ways, including by reducing the available 
avenues through which poor males are able to cope with stress12. This relationship is 
complicated, however, and appears to be somewhat modulated by structures of primary 
economic support within households; working women with unemployed partners are at 
greater risk for IPV, whereas situations where a woman and her partner are supported 
by a third party show decreased rates of IPV12.  Other characteristics of intimate 
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relationships, such as frequency of verbal disagreements or other conflicts, are also 
associated with an increase in physical violence12. Increased rates of IPV are seen in 
situations where IPV is seen as a social norm: boys whose mothers were abused are 
more likely to abuse their partners as adults, and girls whose mothers were abused are 
more likely to be abused themselves as adults12. The prevalence of IPV in rural 
communities may be even greater than in non-rural communities, affected by factors 
such as social/geographical isolation, limited access to healthcare services and 
resources, and poverty5. However, other research has demonstrated no significant 
correlation between risk and urban vs. rural populations12. Several other personal 
characteristics have been associated with increased likelihood of perpetrating IPV, 
including criminal history, history of substance use, unemployment, and being a former 
partner of the victim15. While young males are more likely to perpetrate IPV than older 
males11, age, race, and alcohol use of female victims have not been demonstrated to 
have a significant effect on rates of IPV11. However, since young females may be 
involved in intimate partner relationships with young males at disproportionate rates 
compared to older women, it may be that young age represents an indirect risk factor 
for experiencing IPV in women11. Termination of relationships does not necessarily lead 
to a cessation of IPV, and is actually associated with an increase in severity of IPV21. 
One study documented that half of women murdered by their partners were killed after 
the termination of a relationship10. 
Despite increasing recognition of IPV as a medical and public health problem, 
rates of screening and assessment for IPV by healthcare providers are routinely low6-7, 
17, 23. Estimates of screening rates of women in primary care settings are 5-10%, while 
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rates are estimated to be 5-25% in emergency room settings7. Mental health 
professionals document IPV in case notes at a rate of 10-30%24. Actual rates of IPV in 
women seeking care in primary care settings are estimated to be 15%, suggesting that 
primary care practitioners regularly treat victims of IPV regardless of whether or not they 
are aware of it25. Furthermore, 25-37% of patients presenting to primary care practices 
have experienced IPV in their lifetimes17.  
 
 Roles of Physicians in Addressing IPV 
There are many societies and professional organizations for physicians that 
provide guidelines for when and how patients should be screened for exposure to IPV in 
the healthcare setting. For example, the United States Preventive Services Task Force 
(USPSTF) recommends that women of childbearing age should be screened for IPV26, 
whereas the Institute of Medicine (IOM) recommends that screening for all women and 
adolescent girls should be provided at their physician’s office27. The American Academy 
of Family Physicians (AAFP) recommends that physicians should discuss IPV with their 
patients in a non-judgmental manner28. The Liaison Committee on Medical Education 
(LCME) states that medical schools must prepare their students to treat their patients 
for exposure to violence and abuse29. Additionally, the Joint Commission on 
Accreditation of Healthcare Organizations has mandated that clinics and hospitals must 
provide interventions on behalf of identified victims of IPV30.  
 Studies which have investigated the perspectives of patients and victims suggest 
that these populations feel that physicians have a variety of roles relating to IPV 
exposure1, 30. Female patients (both with and without history of IPV exposure) largely 
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believe that physicians have a role in screening for IPV25. Female victims also feel that 
physicians should provide support or access to resources rather than merely identifying 
IPV1. Female survivors of IPV emphasize the importance of establishing a non-
judgmental and safe environment in which to discuss IPV, and also generally state that 
physicians should provide patients with information and resources for IPV exposure 
regardless of whether or not their patients disclose a history of IPV1, 30. According to a 
study by Chang et al.30, patients expect to be offered both emotional and practical 
support with regards to identified IPV exposure. They feel that establishing an open line 
of communication between patient and physician is an important role for physicians in 
managing IPV exposure. Female patients expect that physicians will have respect for 
patient autonomy and present multiple options for moving forward when a history of IPV 
exposure has been discovered30. In addition, patients stress the importance of safety 
planning and following up with their physicians in the management of IPV exposure30. 
Informational interventions, such as providing flyers with hotline numbers or providing 
information about legal steps that may be taken by victims are generally viewed as 
helpful by victims of IPV30. Conversely, interventions that may make patients feel less 
safe or are damaging to patient autonomy include regular phone call check-ups from 
physicians’ offices, someone from the physician’s office calling the police, or advising 
victims to stay at a shelter30.  
 Primary care physicians, having built strong and trusting relationships with their 
patients, are well positioned to investigate and evaluate complex and/or sensitive social 
issues with their patients3. However, when interviewed about their own capacities 
regarding identifying, evaluating, and managing exposure to IPV, physicians may be 
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unsure of exactly what their roles entail3, though it appears that physicians largely 
believe they have at least some role in identifying IPV in their patients6, 25. 
 
Barriers to Addressing IPV 
A number of studies have attempted to identify the barriers to physicians 
identifying, evaluating, and managing IPV in their patient populations6-7, 23, 31. Such 
studies have revealed a variety of barriers to physicians acting effectively in the roles 
that they, their patients, and several national organizations believe they should have. 
These barriers include physician-related barriers, patient-related barriers, intimate 
partner-related barriers, situational barriers, and resource-related barriers. These 
categories of barriers frequently emerge throughout the literature, and reflect the near-
universal prevalence of such factors which hinder physicians from performing their jobs 
and patients from being adequately served6.  
 Physicians themselves, through a combination of factors, often feel that they are 
inadequately prepared to address IPV7, 25. Providers frequently lack confidence in their 
abilities to identify and manage patients with a history of IPV23, 31. Inefficient provider 
education is also frequently cited as a barrier to screening for IPV4, 23, 32, though 
paradoxically training programs are often poorly attended and it remains unclear as to 
the impact of training programs on IPV screening rates32. One commonly discovered 
barrier is that physicians may believe that there are no effective interventions for 
addressing IPV in their patients. Studies show that this belief may prevent them from 
attempting to identify or evaluate IPV17, 25, 32. Nyame et al.24 demonstrated that 60% of 
mental health professionals surveyed were unfamiliar with available support services for 
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victims of IPV; lack of knowledge of resources constitutes an additional barrier to 
effectively managing IPV. While age of physicians has not been demonstrated to have 
significant impact on physician attitudes toward assisting IPV victims, one study 
demonstrated that white and married physicians are more likely to have negative 
feelings towards working with victims of IPV33. The impact of physician gender is 
unclear with regards to attitudes/beliefs/behaviors regarding IPV. One study found no 
significant effect of physicians’ gender33, while research has found that male physicians 
perceive barriers to addressing IPV more frequently than female physicians17. 
Additionally, physicians in private practice settings identify barriers to managing IPV 
more frequently when compared to physicians working in other settings such as 
hospitals or public clinics17. Overall, though many physicians do report that addressing 
IPV is a medical issue6, 25, interview data has demonstrated that some physicians 
believe that IPV is not within their purview to address in the medical context6, 34. 
 Certain behaviors or attitudes of patients have been identified by healthcare 
professionals as barriers to physicians’ adequately addressing IPV. Patients may be 
reluctant to disclose a history of IPV1, and physicians frequently identify this reluctance 
as a barrier to effectively addressing IPV6, 7. Patients with a history of disclosure of IPV 
without effective evaluation or management by a physician may be reticent to disclose 
any further IPV in the future35. Previous studies reveal that some physicians believe that 
patients do not want to be asked about IPV at their medical appointments, and they are 
concerned that evaluating their patients for IPV will offend them17, 23, 36. Characteristics 
of patients such as lower education and being economically dependent on an abusive 
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partner have been associated with reluctance to disclose IPV for female victims5. These 
factors may be more significant for women in rural settings 5.  
 Barriers to addressing IPV have been found to be associated with the 
perpetrators of IPV. Physicians may endorse feelings of apprehension or fear regarding 
their being targeted for aggression or retribution by perpetrators of IPV if they engage in 
discussions with victims of IPV6, 22. This may be particularly true if physicians become 
aware of a criminal history associated with a perpetrator of IPV6. If physicians are 
responsible for providing care to both victims and perpetrators of IPV, they may 
experience difficulty maintaining professional relationships with both parties if IPV is 
addressed6.  
 Situational or structural factors routinely impact the ability of physicians to 
effectively manage IPV.  Lack of time to adequately address IPV during medical 
appointments is cited commonly as a factor which limits the ability of physicians to 
adequately identify, evaluate, and manage IPV in their patients4, 6, 22, 32, 37, 38, just as it is 
frequently cited as a factor which prevents physicians from addressing other preventive 
health care measures, such as smoking cessation or cholesterol screening9. Physicians 
may be reluctant to discuss IPV with their patients when other family members (such as 
children or intimate partners) are present in the room, suggesting that lack of privacy in 
exam rooms may constitute a barrier to asking about IPV39. It has also been 
occasionally documented in the literature that physicians may fear legal complications 
regarding the discovery of IPV in their patients and so may refrain from asking about it7. 
23. Lack of specialized staff support, such as social workers, may negatively impact 
physicians’ ability to adequately address IPV40. 
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 Decreased availability of relevant community resources may influence 
physicians’ attitudes and behaviors towards addressing IPV. Health care providers may 
feel that their workplaces do not have sufficient access to community referral resources 
for IPV24. Additionally, physicians may practice in communities where access to 
specialty management services for IPV are limited, such as rural or impoverished 
areas5. Physicians caring for specific populations, such as the elderly, may be frustrated 
by lack of community resources to address IPV in this population41. 
 
Current Research on Physicians’ Attitudes and Practices in Addressing IPV 
 Previous research in this area has elucidated many of the features of the 
attitudes, beliefs, and practices of physicians regarding identifying, evaluating, and 
managing IPV in their patients. Research has also provided some insight as to the 
variety and relative effectiveness of different interventions intended to increase 
physicians’ abilities to address IPV.  
 Physician attitudes and beliefs towards addressing IPV have been examined 
previously in the literature. Studies which examine physician attitudes and beliefs 
frequently make use of survey instruments or interviewing techniques, either in focus 
groups or individual interviews. Interviews with physicians in focus groups have 
provided insight as to some of the attitudes which health care providers have towards 
IPV6, 25. In describing the experience of working with patients who experience IPV, 
health care providers reflect on the experience as a difficult journey into the unknown, 
opening a “can of worms” or “Pandora’s Box”25, 41. Physicians perceive causes of IPV to 
be related to cultural factors, inequality between genders, attitudes and behaviors of 
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(predominantly female) victims, and perpetrators’ childhood experience6. Regarding 
certain attitudes towards the factors which contribute to IPV in their patient populations, 
attitudes among physicians may differ by gender6. Male physicians are more likely to 
regard denial of sex by a female partner as a contributing cause of male partner 
aggression, are more likely to believe that female victims will enter into abusive 
relationships serially, and are less likely to conceptualize how children may be 
influenced by the presence of IPV in the home6. Female physicians, on the other hand, 
have been found to be more likely to support female partner’s rights to self-
determination in sexual relationships, more likely to view female separation from 
abusive partners as a gradual process, and more likely to consider how children may be 
effected by IPV6.  Perhaps unsurprisingly, when physicians are asked about factors 
which prevent them from adequately addressing IPV in their patient populations, they 
more frequently cite patient factors rather than physician factors contributing to 
inadequate detection and intervention42. 
 Physicians’ practices in addressing IPV have also been studied. Many studies 
have examined the effectiveness of a variety of screening approaches, looking at 
differences in outcomes between routine vs. indicated screening and physician vs. self-
administered screening tools. Physicians who engage in indicated screening for IPV 
have pointed to physical trauma, somatic symptoms, and mental illness as presenting 
complaints which most frequently trigger their screening for IPV5. However, use of 
routine (i.e., non-elective) screening for IPV has been shown to increase identification 
rates of IPV4. Evidence also suggests that self-administered IPV screening, particularly 
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with the use of computer-assisted screening tools, are at least as effective as provider-
administered screening tools for identifying IPV37.  
 Studies which have sought to determine the effectiveness of a variety of 
interventions on influencing behaviors of physicians toward addressing IPV have had 
mixed results. Educational interventions, in which physicians or healthcare providers 
undergo some degree of formal training regarding IPV identification, evaluation, and/or 
management have not been shown to produce significant lasting changes provider 
behaviors4, 9. When educational strategies are combined with other approaches, 
however, such as use of routine screening questionnaires, it may be possible to 
improve identification rates of IPV4, although whether routine identification necessarily 
translates into routine evaluation and development of management plan for IPV is less 
clear22. Combinations of instructional approaches and immersive training experiences - 
such as visits to safe shelters to speak to victims of IPV - have shown to have a modest 
effect on physician knowledge of IPV23. Approaches which confront barriers to 
addressing IPV using systemic-level interventions appear to be successful in increasing 
physicians’ identification and management of IPV32. Systems approaches to addressing 
IPV management may include: institutional support, educational interventions for 
providers, refresher training, implementation of screening protocols, environmental 
prompts like exam room posters, and specialized evaluators trained to address 
domestic violence9, 32, 39, 43, 44. 
 While survey studies have been designed to assess physicians’ beliefs toward 
screening for IPV17, 42, no study was identified which examined US primary care 
physicians’ attitudes and behaviors towards both screening and managing IPV. 
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Identifying physicians’ perceived roles in and barriers to managing IPV represents a 
valuable component of understanding the dynamics surrounding this issue. The 
purpose of this study is to determine what Connecticut primary care physicians’ 
attitudes, beliefs, and practices are related to identifying, evaluating, and managing IPV 
in their patients. 
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Methods 
The target population for this study was self-identifying primary care physicians 
practicing in Connecticut. Data were collected directly from participants via an 
anonymous, self-administered, web-based survey. Development of the survey used in 
this study was informed by tools identified in the literature to assess physician beliefs 
and attitudes concerning IPV6, 31. The survey instrument consisted of 19 questions 
using multiple formats (including multiple choice, Likert-type questions, and open-ended 
questions). The survey collected information about physician’s attitudes and beliefs 
regarding IPV, including identifying what constitutes IPV, what the rates of IPV are in 
their patients, and how comfortable they are with screening for IPV. Additionally, the 
survey asked about any formal training in IPV screening/management, physicians’ 
perceived roles in identifying, evaluating, and managing IPV in their patients, as well as 
barriers toward acting in those roles. The survey questionnaire is attached to this report 
as an addendum. 
The electronic survey was distributed to physicians belonging to any of three 
fields of medical practice: internal medicine, family medicine, and obstetrics/gynecology 
affiliated with the University of Connecticut Health Center (UCHC). Complete email lists 
of UCHC faculty employed in these fields were obtained from individual departments at 
the health center. Excluded from this study were non-physician practitioners and 
physicians practicing in other states. Distribution of the survey was targeted toward 
primary care practitioners, though the survey was sent to some specialists who had 
been included in the complete lists of department faculty. This was done to both 
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maximize survey participation and because some medical specialists do practice 
primary care for certain patient populations (i.e. infectious disease physicians may 
provide primary care to HIV patients).  
Subjects were recruited via email to explain the study and to provide a link to the 
electronic survey. Participants were instructed that the survey was intended to be 
completed by physicians practicing primary care. The survey was sent to 252 
physicians including 124 internists, 119 family physicians and 9 
obstetrician/gynecologists. Physicians received the electronic survey via their email 
accounts and completed it voluntarily if they chose to participate in the study. The 
survey was administered to participants over a period of 6 weeks from February 2016 
through March 2016. 
Data were exported in to Microsoft Excel and organized into tabular form. Where 
applicable, univariate descriptive statistics were calculated including measures of 
central tendency. Data were used to generate frequency distributions relating to 
physicians’ perceived roles and barriers to addressing IPV. Results of the analysis are 
reported below.  
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Results 
Demographics 
The survey was completed by 56 physicians, providing an overall response rate 
of 22%. A summary of participants’ characteristics are displayed in Table 1. The pool of 
respondents consisted of 34 females (61%) and 22 males (39%); the age range 
approximated a normal distribution with the median age located in the 45-54 range. The 
survey was largely completed by physicians practicing in internal medicine (44.6%) and 
family medicine (41.1%), though respondents also included two physicians practicing in 
obstetrics/gynecology, one pediatrician and five physicians who practiced in another 
field of medicine. Physicians who responded to the survey demonstrated a wide range 
of years in practice in their designated field (see Table 1). The largest group of 
physicians reported that they cared for 21-40 patients per week (33.9%): 19.6% stated 
that they cared for 0-20 patients per week while 7.1% stated that they cared for over 
100 patients per week. Finally, 23.2% of respondents characterized their practice 
setting as a private practice clinic, whereas 42.9% chose to further specify their practice 
setting beyond the options offered in the survey. Many of those participants clarified that 
they worked in academic practice settings, either in a hospital or clinic, which made 
sense given the physicians reached through the listservs.  
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Table 1: Demographic and Practice Characteristics of Participants 
Demographic and Practice Characteristics 
Percentage of 
Respondents 
(56) 
Gender     
  Female 60.7%  
  Male 39.3%  
Age    
  25 to 34 12.5%  
  35 to 44 25.0%  
  45 to 54 30.4%  
  55 to 64 23.3%  
  65 or older 8.9%  
Area of Practice  
  Internal Medicine 44.6%  
  Family Medicine 41.1%  
  Pediatrics 1.8%  
  Obstetrics/Gynecology 3.6%  
  Other 8.9%  
Years in Practice   
  0-10 years 23.6%  
  11-20 years 30.9%  
  21-30 years 25.5%  
  31-40 years 16.4%  
  Over 40 years 3.6%  
Patients per Week  
  0-20 patients per week 19.6%  
  21-40 patients per week 33.9%  
  41-60 patients per week 19.6%  
  61-80 patients per week 8.9%  
  81-100 patients per week 10.7%  
  Over 100 patients per week 7.1%  
Practice Setting  
  Private Practice Clinic 23.2%  
  Community Health Clinic 7.1%  
  
Federally Qualified Health 
Center 7.1%  
  Urgent Care Center 0.0%  
  Emergency Room 0.0%  
  Hospital 19.6%  
  Other 42.9%  
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Physician Definition and Description of IPV 
All physicians participating in the survey readily identified both physical violence 
and sexual violence as elements of IPV. The vast majority of respondents stated that 
psychological aggression constituted IPV (98.2%), and that stalking was included in the 
definition of IPV (87.5%). Several physicians also volunteered additional specific 
behaviors which they considered to be IPV, including isolation of victims, control of 
partner finances, and abuse of household pets. The above results are summarized in 
Table 2. 
Physicians were asked if they considered IPV as a physical health problem, a 
mental health problem, or both a physical and mental health problem for their patients. 
Overwhelmingly, physicians responded that IPV is both a physical and mental health 
problem (89.3%), with 1.8% and 8.9% of physicians identifying IPV as a predominantly 
physical and predominantly mental health problem respectively. These results are 
presented in Table 2. 
 
Lifetime Prevalence of IPV 
Physicians were asked to estimate the prevalence of lifetime exposure to IPV for 
their female and male patients. Physicians responded with a wide range of estimates for 
lifetime rates of IPV in their female patients, with estimates ranging from 1% to 50% of 
female patients experiencing IPV over their lifetimes. The mean of the estimated lifetime 
exposure to IPV for female patients was 18.2% (from 48 useable responses to the 
survey item), with a median of 15%. Certain physicians’ estimates of prevalence 
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included ranges of values (e.g. 10-30%), and so could not readily be included in the 
calculation of the mean, median, and mode of the dataset. 
 
Table 2: Physicians’ Definition and Description of IPV 
IPV Definitions 
Percentage 
of 
Respondents 
(56) 
IPV Elements   
  Physical Violence 100%  
  Sexual Violence 100%  
  Stalking 87.5%  
  Psychological Aggression (including 
coercive tactics) 
98.2%  
  
Description of 
IPV    
  
Predominantly physical health 
problem 1.8%  
  
Predominantly mental health 
problem 8.9%  
  
Both physical and mental health 
problem 89.3%  
 
When asked about lifetime exposure to IPV for their male patients, physicians 
also reported a wide range of estimates from 0% to 25%. The mean estimate lifetime 
exposure to IPV for male patients was 6.9%, with a median of 5%.  
 
Approach to Screening Behaviors 
 Nearly 60% of physicians surveyed indicated that they were either “very 
comfortable” or “comfortable” with screening for IPV in their patients (see Table 3). Less 
than 9% of physicians reported that they were “uncomfortable” or “very uncomfortable  
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with screening”, and 32.1% of physicians said they were neither comfortable nor 
uncomfortable with screening their patients for IPV (Table 3). 
 Physicians were asked about their approach to screening for IPV in their female  
and male patients. A few physicians stated that they do not screen their female patients 
for IPV (Table 3). When asked about indicated screening, or screening which takes 
place when a physician is suspicious that IPV may be occurring, one-fourth of 
physicians indicated that they occasionally engage in such screening when their female 
patients present with symptoms such as bruises, trauma, or depression. Another 30.4% 
of physicians reported that they regularly perform indicated screening for IPV in their 
female patients. Routine screening, or screening that is performed regardless of patient 
presentation, was performed occasionally for female patients by 21.4% of physicians 
and regularly by 14.3% of physicians.   
When physicians were asked about their IPV screening approaches for their 
male patients, they were much less likely to do so. One out of four physicians said that 
they do not screen for IPV in their male patients at all (Table 3). Two out of five 
physicians reported occasionally engaging in indicated screening of male patients while 
less than one out of five reported regularly engaging in indicated screening for IPV. Only 
5.7% of respondents did routine screening occasionally for IPV in male patients, and 
7.5% reported performing regular routine screening. 
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Physicians’ Perceived Roles in Identifying, Evaluating, and Managing IPV 
 Physicians strongly believed that they have a role in screening for IPV in their 
patients, with over 85% of physicians either indicating that they “agree” or “strongly 
agree” with that statement (Table 4).  
Physicians were asked about their role in providing information to their patients 
about IPV, both for identified victims of IPV and for all of their patients regardless of 
victim status. Only 10.7% of physicians did not agree that physicians should provide 
information about IPV to their patients regardless of victim status, and all physicians 
agreed that physicians should provide information about IPV to identified victims of IPV. 
The physicians were less likely to endorse broadly providing information about IPV to 
patients regardless of whether they were identified as a victim or not.  Fifty-nine percent 
of physicians either “agreed” or “strongly agreed” that physicians should provide 
information to their patients about IPV regardless of whether or not they are identified as 
a victim of IPV. Over 95% of physicians agreed that physicians should provide such 
information to victims of IPV. 
Physicians overwhelmingly agreed that they have a role in providing supportive 
counseling to victims of IPV (82.1%) and to make safety plans with victims of IPV 
(78.6%).  Physicians were additionally asked about their perceived roles in referring 
victims to specialty counseling services, to follow up with victims of IPV, and to report 
IPV to law enforcement authorities. Almost all (98.1%) of physicians “agreed” or 
“strongly agreed” that they should be referring victims of IPV to specialty counseling 
services.  
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Table 3: Physicians’ Comfort Level and Screening Practices for IPV in Female and 
Male Patients 
Comfort Level and Screening Practices 
Percentage of 
Respondents 
(56) 
Comfort Level with Screening   
  Very Comfortable 7.1%  
  Comfortable 51.8%  
  Neither Comfortable nor Uncomfortable 32.1%  
  Uncomfortable 7.1%  
  Very Uncomfortable 1.7%  
Screening of Female Patients  
  I do not screen for intimate partner violence. 8.9%  
  I occasionally screen for intimate partner violence when 
my patients present with symptoms which make me 
suspicious that they are being abused (e.g. 
bruises/trauma, depression, etc.) 
25.0%  
  
  
  
  I regularly screen for intimate partner violence when my 
patients present with symptoms which make me 
suspicious that they are being abused (e.g. 
bruises/trauma, depression, etc.) 
30.4%  
  
  
  
  I occasionally screen for intimate partner violence in my 
patients regardless of their presentation. 
21.4%  
  
  I regularly screen for intimate partner violence in my 
patients regardless of their presentation. 
14.3%  
  
Screening of Male Patients  
  I do not screen for intimate partner violence. 26.4%  
  I occasionally screen for intimate partner violence when 
my patients present with symptoms which make me 
suspicious that they are being abused (e.g. 
bruises/trauma, depression, etc.) 
41.5%  
  
  
  
  I regularly screen for intimate partner violence when my 
patients present with symptoms which make me 
suspicious that they are being abused (e.g. 
bruises/trauma, depression, etc.) 
18.9%  
  
  
  
  I occasionally screen for intimate partner violence in my 
patients regardless of their presentation. 
5.7%  
  
  I regularly screen for intimate partner violence in my 
patients regardless of their presentation. 
7.5%  
  
   
 
 
24 
 
 
Physicians were more ambivalent about their role in reporting IPV to law 
enforcement authorities. Only 37.5% of physicians either “agreed” or “strongly agreed” 
that physicians should report IPV to law enforcement, while 28.6% disagreed. These 
data are summarized in Figure 1.  
 
Table 4: Physicians’ Perceived Roles in Addressing IPV 
 
 
Training in Management of IPV 
 Half of physicians surveyed reported that they had formal training in how to 
address IPV in their patients (Table 5). Of the physicians who reported they had 
Proposed Role 
Physicians' Agreement With Proposed Role (56) 
Strongly 
Disagree Disagree 
Neither 
Agree Nor 
Disagree Agree 
Strongly 
Agree 
Physicians should screen 
patients for IPV. 0.0% 3.6% 8.9% 50.0% 37.5% 
Physicians should provide 
information to 
patients about IPV regardless 
of victim status. 0.0% 10.7% 30.4% 30.4% 28.6% 
Physicians should provide 
information to 
victims about IPV. 0.0% 0.0% 1.8% 37.5% 60.7% 
Physicians should provide 
supportive counseling to 
victims of IPV. 0.0% 5.4% 12.5% 37.5% 44.6% 
Physicians should make safety 
plans with victims of IPV. 0.0% 3.6% 17.9% 37.5% 41.1% 
Physicians should follow up 
with victims of IPV. 0.0% 0.0% 14.3% 41.1% 42.9% 
Physicians should report IPV to 
law enforcement. 10.7% 17.9% 33.9% 25.0% 12.5% 
Physicians should refer victims 
of IPV to specialty counseling 
services. 0.0% 0.0% 1.8% 30.4% 67.9% 
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received training, 52.9% had training with in-person lectures or didactic sessions, while 
15.7% indicated that they had training in how to manage IPV via online  
 
 
modules, and 13.7% had training with standardized patients or other applied training. 
When asked to rate the quality of their training, only one physician reported that his/her 
training had been “excellent.” One-third of physicians stated that their training had been 
either “very good” or “good.” More than one-in-three (35.6%) rated their training as only 
“fair” or “poor.”  
 
Barriers to Identifying, Evaluating, and Managing IPV 
 Physicians were asked to indicate to what degree various factors limited their 
ability to address IPV in their patients. These results are summarized in Table 6 and  
Figure 2. 
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Figure 1: How much do you agree that physicians have the 
following roles in addressing Intimate Partner Violence (IPV) in 
their patients?
Strongly Disagree
Disagree
Neither Agree nor
Disagree
Agree
Strongly Agree
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Lack of time in patient visits appeared to be an important factor in addressing IPV 
among primary care physicians, and was the most frequently identified barrier among 
physicians.  More than one-quarter of physicians stated that lack of time during 
appointments to discuss IPV completely prevents them from addressing IPV in their 
patients, and another third reported that this barrier prevents them from addressing IPV 
by a large amount. Only 5.6% of physicians stated that lack of time at appointments 
does not prevent them from addressing IPV. 
One-third of physicians stated that insufficient access to social services for IPV 
for their patients did not prevent them from addressing IPV. However, 42.6% said that 
this prevents them by at least a moderate amount, including 7.4% who stated that this 
factor completely prevents them from addressing IPV in their patients. 
Physicians were also asked about patient-related factors which may contribute to 
their ability to address IPV. Patient reluctance to disclose exposure or discuss IPV 
constituted a greater barrier to addressing IPV; only 1.9% of physicians stated this 
completely prevents them from addressing IPV, 22.2% indicated that this prevents them 
from addressing IPV a large amount and an additional 20.4% a moderate amount. 
However, over a third (35.2%) of physicians surveyed indicated that patient reluctance 
to disclose IPV does not disrupt their ability to address IPV. 
A small minority of physicians, 5.7%, reported that lack of privacy during visits 
completely prevents them from addressing IPV. Additionally, 13.2% indicated that this 
prevents them by a large amount. On the other hand, half of physicians said that lack of 
privacy during visits does not prevent them from addressing IPV in their patients at all.  
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Table 5: Physicians’ Formal Training Experiences in IPV 
Training Experiences in IPV 
Percentage 
of 
Respondents 
(56) 
Had Training in IPV   
  Yes 50.0%  
  No 50.0%  
Type of Training 
Received    
  Online modules 15.7%  
  
In-person lectures/didactic 
sessions 52.9%  
  Training with standardized 
patients or other applied 
training 
13.7%  
  
  N/A 41.2%  
Quality of Training 
Received    
  Poor 8.9%  
  Fair 26.8%  
  Good 23.2%  
  Very Good 10.7%  
  Excellent 1.8%  
  N/A 28.6%  
 
When asked if insufficient knowledge about available resources in the community 
for patients constituted a barrier to managing IPV, almost half indicated that this factor 
limited their ability to address IPV at least moderately. 
Physicians were also asked about their concern regarding aggression from 
perpetrators of IPV towards their patients. Almost 15% of physicians reported that this 
completely prevents them from addressing IPV or does so by a large amount. Almost 
one-fourth (18.5%) of physicians stated that fear of perpetrator aggression toward their 
patients prevents them from addressing IPV by a moderate amount, with 37.0% 
indicating that it does so by a small amount. Nearly one-third (29.6%) of physicians 
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Proposed Barrier 
Physicians' Perceived Impact of Proposed Barriers (54) 
This 
completely 
prevents me 
from 
addressing 
IPV. 
This prevents 
me from 
addressing 
IPV a large 
amount. 
This prevents 
me from 
addressing 
IPV a 
moderate 
amount. 
This prevents 
me from 
addressing 
IPV a small 
amount. 
This does not 
prevent me 
from 
addressing 
IPV. 
Insufficient educational 
preparation to address IPV 0.0% 11.1% 22.2% 42.6% 24.1% 
Insufficient knowledge about 
intimate partner violence (i.e. 
definition of IPV, types of 
IPV) 0.0% 9.3% 18.5% 29.6% 42.6% 
Insufficient knowledge about 
available resources in the 
community for patients  3.7% 13.0% 31.5% 25.9% 25.9% 
Lack of confidence in your 
ability to address IPV 1.9% 3.7% 27.8% 33.3% 33.3% 
Lack of confidence that 
addressing IPV will yield 
meaningful outcomes for 
your patients 3.7% 5.6% 18.5% 25.9% 46.3% 
Patient reluctance to 
disclose exposure or discuss 
IPV 1.9% 22.2% 20.4% 20.4% 35.2% 
Patient noncompliance with 
recommendations related to 
IPV 1.9% 3.8% 7.5% 26.4% 60.4% 
Asking about IPV may harm 
the relationship between you 
and your patient 0.0% 5.6% 7.4% 14.8% 72.2% 
Concern about aggression 
from perpetrators of IPV 
towards you 0.0% 0.0% 9.3% 24.1% 66.7% 
Concern about aggression 
from perpetrators of IPV 
towards your patient 1.9% 13.0% 18.5% 37.0% 29.6% 
Having a dual role caring for 
both victim and perpetrator 
of IPV 1.9% 9.3% 20.4% 16.7% 51.9% 
Lack of time during 
appointments to discuss IPV 22.2% 33.3% 20.4% 18.5% 5.6% 
Lack of privacy during visits 
to discuss IPV with patients 5.7% 13.2% 11.3% 18.9% 50.9% 
Insufficient access to social 
support services for IPV for 
your patients 7.4% 20.4% 14.8% 24.1% 33.3% 
Table 6: Physicians’ Perceived Barriers to Addressing IPV 
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stated, however, that concern of perpetrator aggression toward their victim does not 
prevent them from addressing IPV in their patients. 
The majority of physicians (51.9%) stated that the dual role of providing care for 
both victims and perpetrators of IPV does not prevent them from addressing IPV.  
Slightly more than one out of ten physicians reported that having a dual role of caring 
for perpetrator and victim of IPV would prevent them from addressing IPV by a large 
amount or completely. 
Physicians were asked whether or not insufficient educational preparation to 
address IPV was a factor which prevented them from addressing IPV in their patients.  
One-third of physicians indicated that lack of sufficient educational preparation 
prevented them from addressing IPV either by a large amount (11.6%) or a moderate 
amount (22.2%). A smaller number of respondents (27.8%) felt that insufficient 
knowledge about IPV (i.e., definition of IPV, types of IPV) prevented them from 
addressing IPV.  
Most physicians were hindered not at all or only to a small extent by a lack of 
confidence that addressing IPV will yield meaningful outcomes for their patients 
completely prevents them from addressing IPV. One-fifth of physicians reported that this 
barrier prevents them from addressing IPV by small amounts and almost half indicated 
that this factor did not disrupt their ability to address IPV. 
Most (60.4%) of physicians said that patient non-compliance with 
recommendations related to IPV would not prevent them from addressing IPV at all and 
another 26.4% felt it would to a small extent. Similarly, few physicians believed that 
asking about IPV might harm the relationship between them and their patient would 
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keep them from addressing IPV. Nearly three-quarters of physicians surveyed (72.2%) 
stated that this factor would not prevent them from addressing IPV, and 14.8% of 
physicians reported that this would prevent them by a small amount. 
One-third of physicians reported that lack of confidence in their ability to address 
IPV was a factor that disrupted their ability to manage IPV in their patients by at least a 
moderate amount. One-third of physicians indicated that lack of confidence did not 
prevent them from addressing IPV in their patients at all. 
Finally, fear of perpetrator aggression toward themselves concerned few 
respondents.  Only 9.3% of physicians reported that fear of perpetrator aggression 
prevents them from addressing IPV a moderate amount, with 24.1% of physicians 
indicating that this prevents them by a small amount. Two-thirds stated that fear of 
perpetrator aggression does not prevent them from addressing IPV. 
When physicians were asked if there were other barriers to addressing IPV in 
their patients, a few elaborated on perceived barriers. One physician summed up 
his/her experience with addressing IPV thusly: 
Unless a patient comes to me with the problem, [I] usually do not have time  
to screen for this, as once found, [I am] not trained as to what to do next.  
Those who have had IPV usually have sought out other resources than my  
office, in that, I think they do not feel comfortable as I am the physician for the  
entire family, including, perhaps the perpetrator.  They, perhaps, like to present  
their best face, or perceive, that perhaps I do not have the training to handle this.  
[It is an] interesting topic. Perhaps the reluctance is "opening a bag of worms"  
and not having or knowing the resources available to "positively" deal with it. 
 
Another physician questioned his/her ability to address IPV in his/her patients 
adequately: 
Although I have been trained to ask the questions, my rate of return is so low  
that I wonder if these questions are effective or if my delivery is wrong. I don't  
feel confident in my ability to 100% be able to help a patient in real time.  For  
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instance, if my social worker is not here on that day - I'm not sure what my back-
up plan is - particularly if the patient does not feel safe going home.   
 
Another physician provided his/her opinion about the most effective arrangement for 
addressing IPV in the health care settings: “Physicians should screen; others should 
take the screen and referral and handle counseling, advocacy. Physicians don't have 
the time.” 
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Summary and Discussion 
Attitudes, Beliefs, and Practices Regarding Identifying/Evaluating IPV 
The purpose of this study was to describe what primary care physicians’ 
attitudes, beliefs, and practices are with regard to identifying, evaluating, and managing 
IPV in their patients. Identifying IPV is a multi-stage process which requires at a 
minimum an understanding of the fundamental nature of the problem. Comprehending 
the elements of IPV is a crucial step toward successfully identifying IPV. In keeping with 
CDC guidelines for defining IPV, all physicians responded that physical and sexual 
violence constitute IPV, and the vast majority of respondents agreed that psychological 
aggression and stalking were also elements of IPV. The physicians are familiar with the 
basic definition of IPV and should be in a position to at least recognize it in the course of 
taking clinical histories from their patients. Stalking was the least frequently identified 
element of IPV; this likely reflects that stalking has been recognized as a component of 
IPV more recently than has the other manifestations the survey asked about, and 
physicians are likely less familiar with the updated definition of IPV. 
 Physicians also overwhelmingly recognized that IPV is both a physical and 
mental health problem for patients, reflecting an appreciation that IPV, both in its causes 
and its effects, has the potential to have a powerful impact on victims’ physical and 
mental health. Almost one-in-ten of surveyed physicians stated, however, that IPV is 
predominantly a mental health problem; perhaps reflecting the belief that underlying 
mental illness may predispose individuals to experiencing IPV, though there is no 
evidence to support this in the literature. 
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 Half of the physicians surveyed reported that they had not received formal 
training in how to address IPV. Of those who did receive training, one-in-three stated 
their training was either “fair” or “poor”. This suggests a lack of effective training in IPV 
management.  
 While physicians do appear to readily identify what sorts of behavior constitute 
IPV, physicians’ estimates of prevalence rates of lifetime IPV reflect the fact that many 
may not fully appreciate the degree to which this problem affects their patients. 
Physicians estimated that their female patients have lifetime exposure of between 5-
50%, with an average estimated lifetime prevalence of 18.2%. According to data from 
the CDC, 22.3% of women have been a victim of severe physical violence at the hands 
of an intimate partner over their lifetimes2. Though CDC reports that over one in five 
women have experienced IPV over their lifetimes, other studies have indicated that the 
prevalence rate of IPV in the primary care setting may be closer to 15% for female 
patients25. For male patients, surveyed physicians estimated that 0-25% had lifetime 
exposure to IPV, with an average estimated prevalence of 6.9% over their lifetimes. 
CDC data on lifetime prevalence of severe physical violence against men indicate that 
14.0% experience violence committed by an intimate partner. These data suggest that 
the physicians surveyed are almost certainly underestimating rates of IPV in their male 
patients.  
 When asked about screening patients for IPV, the almost 60% of physicians 
reported that they were at least comfortable with screening, and almost a third more 
answered that they were neither comfortable nor uncomfortable with screening. This 
suggests that, while barriers certainly exist to prevent physicians from screening for IPV, 
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comfort level with screening does not constitute a significant barrier for this surveyed 
sample. Physicians were also asked to respond about their specific screening 
approaches for male and female patients. Only 14.3% of physicians reported performing 
routine screening regularly for their female patients. Recommendations for IPV 
screening in female patients are that physicians should perform routine rather than 
indicated screening and, presumably, regular routine rather than occasional routine 
screening for IPV26-27. These data suggest that most physicians are not performing IPV 
screening according to recommendations put forward by USPSTF and the IOM for 
screening female patients for IPV. There are no recommendations available for 
specifically screening male patients for IPV. In this study, 26.4% of physicians stated 
that they do not screen for IPV in their male patients at all, and 41.5% state that they 
only occasionally engage in indicated screening for IPV. Overall, these data indicate 
that physicians are not likely performing screening in a way as to optimally discover IPV 
in their patients. 
 While these data suggest that physicians are not likely adequately screening for 
IPV in their patients, nearly nine-in-ten physicians surveyed believe that physicians do 
have a role in screening their patients for IPV, and that they believe that IPV is a 
medical issue. Indeed, many do perform some degree of screening especially for their 
female patients.  
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Attitudes, Beliefs, and Practices Regarding Managing IPV 
A majority of physicians endorsed a variety of roles for themselves in managing 
IPV. In this study, almost all felt that they should provide information to victims of IPV 
and more than half also agreed that they should provide information to patients 
regardless of whether or not they are identified as victims of IPV. These basic 
informational interventions are also viewed favorably by victims of IPV1, and therefore 
represent a valuable point of consensus between doctor and patient regarding an 
appropriate intervention for managing IPV.  
Most physicians also perceived that they have a role in providing supportive 
counseling for IPV, and that physicians should create safety plans with their patients 
who are victims of IPV. Responses to these two survey items suggest that physicians 
believe that they should be acting in a counseling role, providing support and safety 
planning interventions themselves. Physicians overwhelmingly agreed that they should 
follow up with victims of IPV after they were identified.  
Physicians were divided by the proposed role of reporting IPV to law 
enforcement agencies. A study which sought to determine victims’ perspectives on 
physicians’ roles regarding IPV found that victims were divided on the issue of reporting 
to police, as well30. On the other hand, physicians nearly unanimously agreed that 
referrals should be made to specialty counseling services for victims of IPV. 
A number of barriers were identified which prevent physicians from adequately 
addressing IPV for their patients. Situational barriers were perceived to be the most 
significant disruptors by physicians, with lack of time during appointments to discuss 
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IPV most frequently identified. Lack of time during appointments was the most 
commonly identified barrier to addressing IPV for patients. Another situational barrier, 
the lack of privacy during visits to discuss IPV, was not identified as a significant barrier 
by most physicians, with over half (50.9%) stating that this does not prevent them from 
addressing IPV.  
A resource-related barrier, insufficient access to social support services for IPV, 
was perceived in a mixed way by the sample. 20.4% perceived that this prevented them 
from addressing IPV by a large amount, while 7.4% stated that it completely prevents 
them from addressing IPV. One third (33.3%) indicate that this does not prevent them 
from addressing IPV at all. The variability in response to this particular factor likely 
reflects the varied demographic and socioeconomic situation of the patients treated by 
the surveyed physicians. Whereas insufficient access to social support may not be a 
significant barrier in affluent communities, patients from poorer communities (and the 
physicians who work there) may have trouble accessing sufficient social support 
systems. 
Physician-related barriers, such as insufficient educational preparation to 
address IPV and insufficient knowledge about IPV were not strongly identified as 
barriers to addressing IPV. Additionally, physicians’ lack of confidence in their ability to 
address IPV was not identified as a significant barrier, with 66.7% of physicians 
indicating that this prevented them from addressing IPV by a small amount or not at all. 
Insufficient knowledge of community resources was identified as a barrier slightly more 
frequently, with 3.7% of physicians stating that this completely prevents them from 
addressing IPV and 13.0% indicating that it prevents them by a large amount. Still, 
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25.9% indicate that this prevents them from addressing IPV by only a small amount and 
another 25.9% say that this does not prevent them from addressing IPV at all. This 
study demonstrated that, from physicians’ perspectives, physician-related barriers are 
not perceived as significantly impacting their ability to address IPV.  
Certain patient-related factors were perceived to be more significant barriers to 
addressing IPV. Patient reluctance to disclose IPV or discuss IPV was identified as 
preventing physicians from addressing IPV a large amount by 22.2% of physicians. 
Despite this, 55.6% of physicians perceived that this barrier prevented them from 
addressing IPV by a small amount or not at all. Other patient-related factors, such as 
lack of confidence that addressing IPV would yield meaningful outcomes for patients, or 
patient noncompliance with recommendations relating to IPV were not identified as 
significant barriers by this sample of physicians. Additionally, few physicians reported 
that potential harm to patient-doctor relationship constituted a significant barrier to 
addressing IPV.  
Some physicians did report that they perceived the threat of aggression from 
perpetrators of IPV towards their patients as a barrier to addressing IPV, with 13.0% of 
physicians and 18.5% of physicians surveyed identifying this as preventing them by a 
large amount and a moderate amount respectively. Other perpetrator-related barriers, 
such as concern about aggression from perpetrators of IPV toward physicians and 
having a dual role caring for both victim and perpetrator of IPV were not frequently cited 
as significant barriers.  
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The accounts provided by physicians relating to their experiences working with 
IPV largely mirror physicians’ accounts in the literature. Working with patients who 
experience IPV is frequently described as opening “Pandora’s Box” or “a can of 
worms”25, 41; physicians in this study provided similar metaphors for their own 
experiences. 
 
 Limitations 
 This study has several limitations which influence the interpretation of these 
results. Firstly, a sample of only 56 physicians completed the survey, and therefore 
these results may not be generalizable to the larger populations of physicians in 
Connecticut or the US. Because of the modest sample size, univariate descriptive 
statistics and frequencies were used to describe the data, though the nature of these 
descriptions do not allow for any quantifiable inferential interpretation of the data.  
 The sample was primarily recruited from a population of physicians working in 
and around a large academic medical center. This population of physicians and the 
patients whom they treat may not be representative of the general population of 
physicians/patients of the state or the nation, and therefore the results of this study 
should be interpreted cautiously.  
 The study was primarily designed to target primary care physicians, as these 
doctors are best positioned to identify, evaluate, and manage sensitive and complex 
issues such as IPV. The survey was distributed to primary care physicians and 
specialists with the intent that it would be completed by those who might realistically be 
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in a position to evaluate their patients for IPV. It is possible that the survey was 
completed by a few physicians who may not be in such a position. It is unlikely that a 
physician with no self-identified role in addressing IPV would have completed the 
survey.  
 IPV is a complex issue that transcends physical, mental, and psychosocial 
realms of health. There are a myriad of factors and barriers which are at play to 
influence how physicians and patients respond to it. A survey is reductionist by nature 
and may not allow respondents to completely describe their beliefs and attitudes 
accurately. This limitation and those previously mentioned suggest that a narrow 
interpretation of the above results may be most appropriate.  
 
 Summary 
 This study demonstrated that physicians are familiar with the basic elements of 
IPV and perceive IPV as both a mental and physical health problem. Physicians are 
screening their female and male patients for IPV, though this screening is not performed 
as often as is recommended and therefore it is likely that physicians are not detecting 
IPV that they would have otherwise discovered with more consistent screening. 
Physicians overwhelmingly believe that IPV is within their purview to address in the 
medical context and believe they have roles in screening patients for IPV, providing 
information to patients about IPV, providing counseling and making safety plans with 
patients, and following up/referring to specialty services. Physicians perceive significant 
barriers to addressing IPV, especially related to systems-level factors such as lack of 
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time during appointments to discuss IPV and insufficient access to community 
resources for patients. Some physicians also report that patient reluctance to disclose 
exposure or discuss IPV is a significant barrier to addressing IPV. There is certainly 
more research that needs to be done to continue to develop an understanding of IPV. 
 
 Conclusion 
 Future research in this field could seek to further define the features of some of 
the more significant barriers that physicians report when addressing IPV. A study 
focusing on the barrier of insufficient time to address IPV during patient visits, and 
determining more clearly the details of what that barrier means in practice, may help to 
develop solutions for how physician time might be optimized to better address IPV. 
Additionally, a study might examine how simple environmental prompts, such as posters 
or pamphlets, focused on IPV might impact voluntary disclosure of IPV by male and 
female patients. Informational interventions are well regarded by both physicians and 
victims of IPV, and so further investigating how these may be more effectively applied 
could provide insight as to how to more effectively address IPV in the clinical setting. 
There is clearly an opportunity for improved training of physicians to recognize and 
address IPV, with more hands-on and simulated training likely to produce more lasting 
results than lectures or online modules. Finally, strengthening networks between 
physicians’ offices and community resources for assisting patients with IPV would be a 
crucial step in addressing access-related barriers. IPV is such a multifaceted issue; it 
will take a similarly multifaceted approach to address in a meaningful way.  
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Appendix I: Survey of Physicians on IPV 
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